Dr. Benowitz: "Dr. Benowitz, as a paid consultant for pharmaceutical companies, has assisted them with the design, development, and marketing of smoking-cessation products. Among the companies for which he has consulted on such products are GlaxoSmithKline plc and its affiliates (collectively, “GSK”); Pfizer, Inc. and its affiliates (collectively, “Pfizer”); Novartis AG and its affiliates (collectively, “Novartis”); Sanofi-Aventis U.S. LLC and its affiliates (collectively, “Sanofi-Aventis”); and Aradigm Corp. and its affiliates (collectively, “Aradigm”). During the last ten years, he has received at least approximately $10,000 per year for such consulting. He has also received grant support for research and writing from GSK and/or Pfizer on at least five occasions. In 2010, he co-authored a study, funded by Pfizer, on the use of its drug, Chantix, for smoking cessation."

The black box warning for Chantix, which is required by the FDA to be placed on this smoking cessation drug made by Pfizer, notes the following:

You may wonder why I am calling these people - smokers who have quit smoking via electronic cigarettes - anecdotes.

Thus, before even conducting the study, these researchers have concluded that adult smokers and their family members are severely affected if they undergo surgery and return to a THS-polluted environment, because their healing process will be significantly delayed. Also, the researchers have concluded that individuals who are repeatedly exposed to thirdhand smoke have impaired healing. This includes elderly parents in households with smokers as well as housekeepers in hotels.

LAST：2014 new high quality dry herb vaporizer pen Colorful CE4 Clearomizer click n vape |NEXT：alibaba ecig accessory golden supplier BDC X-Air clearomizer